mRNA-Based Biomarker Identification for Targeted Therapy Development in Pancreatic Cancer
Pancreatic cancer is one of the highly malignant cancers that have poor prognosis and limited treatment options. The development of targeted therapies is important for improving patient outcomes. In this study, we analyzed the datasets from the GEO database to identify potential mRNA biomarkers for...
Saved in:
| Main Authors: | Saima Firdaus, Rafat Parveen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Series: | Biology and Life Sciences Forum |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2673-9976/43/1/2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Novel mRNA biomarker-based liquid biopsy for the detection of resectable pancreatic cancer
by: Jong-chan Lee, et al.
Published: (2025-04-01) -
Deep sequencing reveals distinct microRNA-mRNA signatures that differentiate pancreatic neuroendocrine tumor from non-diseased pancreas tissue
by: N Matyasovska, et al.
Published: (2025-04-01) -
Urinary sediment mRNA as a potent biomarker of IgA nephropathy
by: Jin Sug Kim, et al.
Published: (2024-11-01) -
Personalized medicine in pancreatic cancer: Harnessing the potential of mRNA vaccines
by: Aariz Hussain, et al.
Published: (2025-03-01) -
Bioinformatic screen with clinical validation for the identification of novel stool based mRNA biomarkers for the detection of colorectal lesions including advanced adenoma
by: Houcong Liu, et al.
Published: (2025-08-01)